West Family Investments, Inc.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1568303
CARLSBAD, CA
Position in ALNY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$230,890
-$25,991 QoQ
Shares Held
767
+18.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#575
of 784 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026West Family Investments, Inc. holds $2,539,425 across 7 Biotechnology names. ALNY ranks #6 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,695 | $841,957 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,017 | $634,140 | |
| 3 | ARGX |
Argenx SE
|
374 | $346,985 | |
| 4 | INCY |
Incyte Corp
|
2,161 | $244,970 | |
| 5 | RPRX |
Royalty Pharma plc
|
4,288 | $240,428 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
767 | $230,890 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
35,500 | $55 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $230,890 | 767 | Shares | Sole | 2026-08-10 | |
| 2025-12-31 | $256,881 | 646 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $374,832 | 822 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $268,045 | 822 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||